About the journal
Journal of Translational Medicine is an open-access journal published by BMC in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,350 EUR. Declared review time at DOAJ: 25 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- BMC
- ISSN
- 1479-5876
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,350 EUR
- Articles in DOAJ
- 8725
- Declared review time
- 25 weeks
- Declared peer-review model
- peer_review
- Official website
- https://translational-medicine.biomedcentral.com/
Index listings
- DOAJ · 2003-12-12
- MEDLINE · 2007-01-01
- PUBMED · 2003-07-24
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 3,350 EUR
- Declared review time (DOAJ)
- 25 weeks
- Actual review time (measured)
- 110 days received→accepted — computed from PubMed (n=96)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
8725
Most recent article
last month
Average review time (journal-declared via DOAJ)
25weeks
Works in OpenAlex
10268
Last recorded publication year
2026
h-index
190
i10-index
6144
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2003-12-12
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- LOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 91%
- ORCID iDs in current deposits
- 71%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- JTM
- Source type
- journal
- NLM unique ID (PubMed)
- 101190741
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune cells in cancer
Show all subjects (50)
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- CAR-T cell therapy research
- CAR-T cell therapy research
- Gut microbiota and health
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Gut microbiota and health
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Single-cell and spatial transcriptomics
- Single-cell and spatial transcriptomics
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Cancer-related molecular mechanisms research
- Mesenchymal stem cell research
- Mesenchymal stem cell research
- Cancer-related molecular mechanisms research
- Extracellular vesicles in disease
- Extracellular vesicles in disease
- Circular RNAs in diseases
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA modifications and cancer
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- Epigenetics and DNA Methylation
- Cancer Genomics and Diagnostics
- Epigenetics and DNA Methylation
- Cancer Genomics and Diagnostics
- Angiogenesis and VEGF in Cancer
- Angiogenesis and VEGF in Cancer
- Cancer Research and Treatments
- Cancer Research and Treatments
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Glioma Diagnosis and Treatment
- Virus-based gene therapy research
- Glioma Diagnosis and Treatment
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Virus-based gene therapy research
- Fibromyalgia and Chronic Fatigue Syndrome Research
Keywords (DOAJ)
- human experimentation
- translational medicine
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ